Analyst Insight Series
Decision Resources' analysts are the leading experts on various healthcare issues, from specific drug market analysis to insights on industry trends.
View a brief presentation by analyst Sylivia Eash, Ph.D., in which she discusses the HIV drug treatment market. Dr. Eash is the author of the Pharmacor report entitled Human Immunodeficiency Virus which finds that the market for HIV therapies will experience robust 5.4 percent annual growth through 2012. Read more and view presentation
View a brief presentation by analyst Sami Fam, Ph.D., in which he discusses the drug treatment market for Parkinson's disease. Dr. Fam is the author of the Pharmacor report entitled Parkinson's Disease which finds that the generic erosion of market leading therapies will constrain the Parkinson's disease drug market. Read more and view presentation
View a brief presentation by analyst Nathan Calloway in which he discusses the drug treatment market for generalized anxiety disorder. Mr. Calloway is the author of the Treatment Algorithms in Generalized Anxiety Disorder report which finds that Lexapro is the leading single agent used in anxiety therapy. Read more and view presentation
Listen to a brief interview with analyst Kathryn Benton in which she discusses the drug treatment market for Crohn's disease. Ms. Benton is the author of the recent Pharmacor report Crohn's Disease which finds that the market for the disease will more than double, from $1.5 billion in 2006 to $4 billion in 2016, in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan. Read more and listen to audio clip
Listen to a brief interview with analyst Kaitlyn Sullivan in which she discusses the drug treatment market for community-acquired pneumonia. Ms. Sullivan is the author of the recent Pharmacor report Community Acquired Pneumonia, which finds that the most promising antibiotics in development for the treatment of community-acquired pneumonia are intravenous agents that will be used in the hospital setting, including Johnson & Johnson/Basilea’s ceftobiprole and Forest’s ceftaroline. Read more and listen to audio clip
Listen to a brief interview with analyst Victor Li, Ph.D., in which he discusses the drug treatment market for liver cancer in China. Dr. Li is the author of the recent Emerging Markets report entitled Liver Cancer in China which forecasts that the Chinese hepatocellular carcinoma (HCC; the most prevalent type of primary liver cancer) market will quadruple between 2006 and 2011. Read more and listen to audio clip
Listen to a brief interview with Irene Koulinska, M.D., in which she discusses the drug treatment market for psoriasis. Dr. Koulinska is the author of the Pharmacor report entitled Psoriasis which finds that Amgen/Wyeth/Takeda's Enbrel will sustain its first-to-market advantage over other biologics and continue to dominate the psoriasis market through 2011. However, Abbott/Eisai's Humira will challenge Enbrel's leading position and reach more than $1 billion in sales by 2016.
Read more and listen to audio clip
Listen to a brief interview with Cindy Mundy, Ph.D., in which she discusses the drug treatment market for urge urinary incontinence. Dr. Mundy is an author of the Pharmacor report entitled Urge Urinary Incontinence which finds that, although novel therapies will contribute to sales growth, anticholinergics, including Pfizer/Schwarz Pharma's Toviaz, will continue to dominate the urge urinary incontinence drug market over the next decade.
Listen to a brief interview with analyst Carlos Dedesma, Ph.D., in which he discusses the drug treatment market for bipolar disorder. Dr. Dedesma is the author of the recent Pharmacor report Bipolar Disorder, which finds that the use of the AstraZeneca's Seroquel XR and Solvay/Lundbeck/Wyeth's bifeprunox will help offset a decrease in the overall bipolar disorder market over the next decade. Read more and listen to audio clip
The Analyst Insight Series from Decision Resources features audio and written presentations from MDs and PhDs with experience in the health care industry. With topics including healthcare market analysis, pharmaceutical treatments, and new regimens for disease, we offer an educational and informative way to stay up to date on new trends in the treatment market.
Decision Resources helps people in the Pharma and medical fields find new markets, discover emerging trends, and offer diverse treatment options to patients worldwide. Given the wide variety of medical care conditions and regulations around the world, it is essential for anyone in the drug marketing field to know all the trends in healthcare market analysis. Furthermore, the doctors who present information also can give firsthand accounts of the cultural and social barriers that may need to be overcome in order to give the best possible treatment. Audio interviews with healthcare professionals and marketing experts make it possible for anyone in the industry to get an overview of the challenges faced in today's pharmaceutical industry. Additionally, new trends and therapies for HIV, Multiple Sclerosis, Drug Resistant TB, and cancer are discussed by doctors who work in every phase of the business from testing to treatment.
